1725153122
A pinch of salt - A podcast by ERA

Advertise on podcast: A pinch of salt - A podcast by ERA

Rating
★★★☆☆
3
from
2 reviews
This podcast has
143 episodes
Language
English
Explicit
No
Date created
2024/01/10
Latest episode
2026/11/12
Average duration
28 min.
Release period
11 days

Description

Welcome to "A Pinch of Salt- A podcast by ERA". Each month, we'll release three episodes with nephrologists and other physicians who have other interests outwith medicine. Hosts: Andrej Skoberne and George KosmadakisAn initiative by ECC – Electronic Communication Committee

Unlock A pinch of salt - A podcast by ERA podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from A pinch of salt - A podcast by ERA podcast


#87 Ten tips on how to manage obesity in the presence of CKD, with Pierre Delanaye (Host) and Nadine Kaesler (Guest)
2026/11/12
Pierre Delanaye, host of this episode, welcomes Nadine Kaesler, co-author of the paper “Ten tips on how to manage obesity in the presence of CKD” published in Clinical Kidney Journal, to discuss the challenges of managing obesity in patients with chronic kidney disease. Discover the key challenges and clinical considerations surrounding obesity management in CKD, and read the full paper for further insights. Nadine Kaesler, Susanne Fleig, Ten tips on how to manage obesity in the presence of CKD, Clinical Kidney Journal, Volume 17, Issue 11, November 2024, sfae317, https://doi.org/10.1093/ckj/sfae317
#86 Antibody-mediated rejection—treatment standard, with Rainer Oberbauer (Host) and Georg A. Böhmig (Guest)
2026/11/12
Rainer Oberbauer is the host of this episode, welcoming Georg A. Böhmig, co-author of the paper “Antibody-mediated rejection—treatment standard” published in the Nephrology Dialysis Transplantation, to discuss the challenges and evolving therapeutic strategies in antibody-mediated rejection (AMR) after kidney transplantation. Discover more about the topic in this episode and explore the full paper for further insights. Georg A Böhmig, Maarten Naesens, Ondrej Viklicky, Olivier Thaunat, Matthias Diebold, Lionel Rostaing, Klemens Budde, Antibody-mediated rejection—treatment standard, Nephrology Dialysis Transplantation, Volume 40, Issue 8, August 2025, Pages 1615–1627, https://doi.org/10.1093/ndt/gfaf097
#85 Top ten tips in managing ANCA vasculitis, with Ana Carina Ferreira (Host) and Min Hui Tan (Guest)
2026/11/12
In this episode, Ana Carina Ferreira takes on the role of host, welcoming Min Hui Tan, co-author of the paper “Top Ten Tips in Managing ANCA Vasculitis” published in the Clinical Kidney Journal, to discuss key challenges and evolving strategies in the management of ANCA-associated vasculitis. Tune in for an insightful discussion and read the full article! Min Hui Tan, David Jayne, Top ten tips in managing ANCA vasculitis, Clinical Kidney Journal, Volume 18, Issue 2, February 2025, sfae389, https://doi.org/10.1093/ckj/sfae389
#84 The failing allograft: more than the rise of creatinine with Annelies de Weerd
2026/10/15
We watch creatinine rise and fall all the time, but a failing kidney allograft is more than a numbers game. Annelies de Weerd (Erasmus MC Rotterdam) covers when to call it failure, the immunosuppression taper, and helping patients through what feels like a step backwards.
#83 CKM syndrome: why you should care, with Amaryllis Van Craenenbroeck
2026/10/15
Heart over there, kidney over here, metabolism somebody else’s problem? Not anymore. Amaryllis Van Craenenbroeck (KU Leuven) makes the case for Cardiovascular-Kidney-Metabolic syndrome as one continuum, not three separated clinics. Four drug classes, three organs, one patient, prevention upstream, and a fair hearing for the sceptics who call it disease-mongering.
#82 POCUS in nephrology: ready for prime time? with Faeq Husain-Syed
2026/10/15
For decades, “volume status” meant a (un)healthy dose of educated guessing. What if you could just look? Faeq Husain-Syed (Giessen) joins "A pinch of salt" to explain how kidney venous Doppler makes congestion visible, and whether Point-of-care Ultrasound is ready for prime time.
Trailer POCUS in Nephrology: ready for prime time?, CKM syndrome: why you should care, The failing allograft: more than the rise of creatinine
2026/10/08
#81 Diuretics in Acute Heart Failure: take them with a “pinch of salt”? with Jozene Ter Maaten
2026/09/10
In acute heart failure, we’re told to take things with a pinch of salt but salt might be exactly what we should watch. Hugo Diniz welcomes Jozine ter Maaten, the principal investigator behind the PUSH-AHF trial, to argue heart failure is a sodium problem dressed as a fluid one — and why a rising creatinine may be a friend, not a foe.
#80 European Specialty Examination in Nephrology: demystifying the ESENeph with David Lappin
2026/09/10
Every nephrology trainee in Europe has heard about it, stressed about it, or is quietly pretending it doesn’t exist: the ESENeph. Is it a genuine European passport, or just one more exam? Hugo Diniz talks to David Lappin, about the exam’s format, its career value, and why trainees should sign up.
#79 Osteoporosis in CKD: when bone and kidneys disagree? with Hanne Skou Jørgensen
2026/09/10
We obsess over PTH, calcium, and phosphate — yet our patients are quietly, inconveniently, fracturing. Hip fracture rates in dialysis patients dwarf the general population, and with very high mortality rates. Hugo Diniz asks Hanne Skou Jørgensen the uncomfortable question: have nephrologists been missing osteoporosis all along? DEXA’s comeback, bone turnover markers, and a practical screening algorithm.
Trailer Osteoporosis in CKD: when bone and kidneys disagree?, European Specialty Examination in Nephrology: demystifying the ESENeph and Diuretics in Acute Heart Failure: take them with a “pinch of salt”?
2026/09/03
#78 B-cell therapy in IgA Nephropathy: worth the hype? with Vlado Perkovic
2026/06/18
For decades, treating IgA nephropathy meant looking thoughtful while saying "let's optimise supportive care and monitor closely." Not anymore. We've gone from one road to a full therapeutic roundabout, and nobody wants the wrong exit. Hugo Diniz welcomes Vlado Perkovic to navigate the new era: anti-APRIL and anti-BAFF agents, the VISIONARY and ORIGIN data, and the 2025 KDIGO framework. Are we finally switching off the disease at its source, or just admiring another elegant proteinuria curve? Vlado helps us separate evidence from excitement, and hype from hope. A new episode of A pinch of salt.
#77 Generative AI for the busy nephrologist: adapt or perish? with Wisit Cheungpasitporn
2026/06/18
Are we all about to be replaced by chatbots? Probably not — but is there a risk of Gen-AI acute tubular necrosis for those who don't adapt? Hugo Diniz is joined by Wisit Cheungpasitporn to demystify what generative AI can actually do, expose what it definitely can't (yet), and make it approachable for every working nephrologist. From automating those soul-crushing clinic notes to navigating the constant flow of new evidence, "vibe coding" your own tools, and the dark side of energy use and patient privacy. AI may not replace your clinical judgment anytime soon — but it might just cure our chronic administrative disease.
#76 Late Breakers, LIVE from Glasgow, with Alberto Ortiz and Danilo Fliser
2026/06/18
This is “A pinch of salt” live from the 63rd ERA Congress! Recorded straight out of a packed Clyde Plenary Room: six trials, ninety minutes! Hugo Diniz, the new podcast host, brings you rapid-fire expert commentary with two titans of European nephrology, Alberto Ortiz and Danilo Fliser. On the menu — a brand-new CKD drug class (nurandociguat), what patients actually feel on semaglutide (FLOW sub-analysis), two IgA nephropathy therapies going long-term (atrasentan and iptacopan), anticoagulation in advanced kidney disease (TRACK), and the first randomised trial of dialysis versus conservative care. An episode you just can’t miss!
Trailer Late Breakers, LIVE from Glasgow, Generative AI for the busy nephrologist: adapt or perish? and B-cell therapy in IgA Nephropathy: worth the hype?
2026/06/11

Podcast reviews

Read A pinch of salt - A podcast by ERA podcast reviews


3 out of 5
2 reviews

Podcast sponsorship advertising

Start advertising on A pinch of salt - A podcast by ERA relevant audience podcasts


What do you want to promote?